Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BEAMS: Morphine for chronic refractory breathlessness in COPD
NCT02720822Phase 3Completed
- Sponsor
- Flinders University
- Start
- Aug 2016
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of morphine in Dyspnea, sponsored by Flinders University. Started Aug 2016; status: completed.
02
Drugs
morphine
03
Conditions
Dyspnea
Beyond the preview
Go deeper on NCT02720822.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02720822.